Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №1 (2025) > Neurological manifestations of rhino-orbito-cerebral mucormycosis

Neurological manifestations of rhino-orbito-cerebral mucormycosis

Ekaterina A. Ruina, Igor A. Korolev, Vera N. Grigoreva, Elena A. Antipenko, Alina S. Misnik, Ksenija A. Golovina

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Mucormycosis is a severe fungal infection that develops in immunocompromised patients. Rhino-orbito-cerebral mucormycosis (ROCM) is the most common and dangerous clinical form of infection, characterized by infection of the nasal cavities, paranasal sinuses, cervical spaces, orbits and intracranial structures. 
Aim. To describe a series of clinical observations, including 8 patients with ROCM from 2019 to 2023, to identify the features of neurological manifestations of ROCM. 
Materials and methods. This article describes our own experience in the management of 8 patients with rhino-orbito-cerebral mucormycosis (ROCM). Neurological syndromes of cranial nerve damage, vascular and inflammatory lesions of the nervous system within the framework of this syndrome are described. 
Results. Neurological complications of RCM were present in all patients and included damage to cranial nerves (in all cases), thrombosis of the cavernous sinuses, strokes and damage to the membranes of the brain. The algorithm of diagnosis of ROCM is presented, the tactics of selection of drug therapy and surgical care in the rehabilitation of foci of mucormycosis are described. The catamnesis was traced in each described case.
Keywords: mucormycosis, rhinocerebral mucormycosis, coronavirus infection, diabetes mellitus.

About the Author

Ekaterina A. Ruina1, Igor A. Korolev2, Vera N. Grigoreva1, Elena A. Antipenko1, Alina S. Misnik1, Ksenija A. Golovina1

1 Privolzhsky Research Medical University, Nizhny Novgorod, Russia

2 Semashko Regional Clinical Hospital, Nizhny Novgorod, Russia

References

1. Cornely OA, Alastruey-Izquierdo A, Arenz D et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019;19(12):e405-e421. DOI: 10.1016/S1473-3099(19)30312-3
2. Pai V, Sansi R, Kharche R et al. Rhino-orbito-cerebral Mucormycosis: Pictorial Review. Insights Imaging 2021;12(1):167. DOI: 10.1186/s13244-021-01109-z
3. Al-Ani RM. Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019. World J Virol 2022;11(5):293-9. DOI: 10.5501/wjv.v11.i5.293
4. Patel A, Agarwal R, Rudramurthy SM, et al. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis 2021;27(9):2349-59. DOI: 10.3201/eid2709.210934
5. Saneesh PS, Morampudi SC, Yelamanchi R. Radiological review of rhinocerebral mucormycosis cases during the COVID-19 Pandemic: A single-center experience. World J Radiol 2022;14(7):209-18. DOI: 10.4329/wjr.v14.i7.209
6. AK AK, Gupta V. Rhino-Orbital Cerebral Mucormycosis. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. PMID: 32491361.
7. Иванюта С.О., Христофорандо Д.Ю., Спевак Е.М., Цымбал А.Н. Постковидный некроз черепно-челюстно-лицевой области. Казанский медицинский журнал. 2023;104(4):552-63. DOI: 10.17816/KMJ119997
Ivanyuta S.O., Christoforando D.Yu., Spivak E.M., Tsymbal A.N. Waxy necrosis of the craniofacial region. Kazan Medical Journal. 2023;104(4):552-63. DOI: 10.17816/KMJ119997 (in Russian).
8. Макаров А.А., Оразвалиев А.И., Ушаков Р.В., Жабко Е.В. Рино-орбито-церебральный мукормикоз, ассоциированный с COVID-19 и диабетом. Российская ринология. 2022;30(3):210-6. DOI: 10.17116/rosrino202230031210
Makarov A.A., Orazaliev A.I., Ushakov R.V., Zhabko E.V. Rhino-orbit-cerebral mucormycosis associated with COVID-19 and diabetes. Russian rhinology. 2022;30(3):210-6. DOI: 10.17116/rosrino202230031210 (in Russian).
9. Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am 2021;35(2):435-52. DOI: 10.1016/j.idc.2021.03.009
10. Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel) 2019;5(1):26. DOI: 10.3390/jof5010026
11. Singh G, Vishnu VY. Neurological manifestations of rhino-oculo-cerebral mucormycosis in the COVID-19 era. Nat Rev Neurol 2021; 17(11):657-8. DOI: 10.1038/s41582-021-00560-2
12. Hoenigl M, Seidel D, Carvalho A et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe 2022;3(7):e543-e552. DOI: 10.1016/S2666-5247(21)00237-8
13. Saravanam PK, Thattarakkal VR, Arun A. Rhino-Orbito-Cerebral Mucormycosis: An Audit. Indian J Otolaryngol Head Neck Surg 2022;74(Suppl. 2):2686-92. DOI: 10.1007/s12070-020-02033-2
14. Ohadi MAD, Banihashemi G, Dilmaghani NA et al. COVID-19-related rhino-orbital-cerebral mucormycosis: Neurological manifestation and related risk factors in two cases. Clin Case Rep 2022;10(10):e6352. DOI: 10.1002/ccr3.6352
15. Abdollahi A, Shokohi T, Amirrajab N et al. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis – A retrospective analysis. Curr Med Mycol 2016;2(4):15-23. DOI: 10.18869/acadpub. cmm.2.4.15
16. Kulkarni NS, Bhide AR, Wadia RS. Rhinocerebral mucormycosis: An analysis of probable mode of spread and its implication in an early diagnosis and treatment. Indian J Otolaryngol Head Neck Surg 2005;57(2):121-4. DOI: 10.1007/BF02907665
17. Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol 2005;262(11):932-8. DOI: 10.1007/s00405-005-0919-0
18. Sravani T, Uppin SG, Uppin MS, Sundaram C. Rhinocerebral mucormycosis: Pathology revisited with emphasis on perineural spread. Neurol India 2014;62(4):383-6. DOI: 10.4103/0028-3886.141252
19. Dubey S, Mukherjee D, Sarkar P et al. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr 2021;15(5):102267. DOI: 10.1016/j.dsx.2021.10
2267
20. Azhar A, Khan WH, Khan PA et al. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach. J Infect Public Health 2022;15(4):466-79. DOI: 10.1016/j.jiph.2022.02.007
21. Patel DD, Adke S, Badhe PV et al. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience. Clin Imaging 2022;82:172-8. DOI: 10.1016/j.clinimag.2021.10.014
22. Luthra G, Parihar A, Nath K et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007;28(7):1332-8. DOI: 10.3174/ajnr.A0548
23. Razek AA, Castillo M. Imaging lesions of the cavernous sinus [published correction appears in AJNR. Am J Neuroradiol. 2009 Aug;30(7):E115]. AJNR Am J Neuroradiol 2009;30(3):444-52. DOI: 10.3174/ajnr.A1398
24. Arikan S, Sancak B, Alp S et al. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol 2008;46(6):567-73. DOI: 10.1080/13693780801975576
25. Lackner M, Caramalho R, Lass-Flörl C. Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol 2014;9(5):683-95. DOI: 10.2217/fmb.14.23
26. Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel) 2019;5(3):59. DOI: 10.3390/ jof5030059
27. Pagano L, Offidani M, Fianchi L et al; GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program. Mucormycosis in hematologic patients. Haematologica 2004;89(2):207-14. PMID: 15003897.
28. Ibrahim AS, Gebremariam T, Schwartz JA et al. Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimicrob Agents Chemother 2009;53(2):772-5. DOI: 10.1128/AAC.01124-08
29. Singh N, Aguado JM, Bonatti H et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 2009;200(6):1002-11. DOI: 10.1086/605445

For citation:Ruina E.A., Korolev I.A., Grigoreva V.N., Antipenko E.A., Misnik A.S., Golovina K.A. Neurological manifestations of rhino-orbito-cerebral mucormycosis. Clinical review for general practice. 2025; 6 (1): 65–73 (In Russ.). DOI: 10.47407/kr2024.6.1.00552


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru